Position in CERS
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$7,026,482
+$2,579,785 QoQ
Shares Held
2,406,330
-1.5% QoQ
Ownership
1.19%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#19
of 185 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CERS Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026IEQ CAPITAL, LLC holds $134,579,177 across 47 Medical Devices names. CERS ranks #8 (5.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TXG |
10x Genomics, Inc.
|
526,390 | $20,181,792 | |
| 2 | ABT |
Abbott Laboratories
|
191,459 | $17,372,989 | |
| 3 | BSX |
Boston Scientific Corp
|
387,250 | $16,527,829 | |
| 4 | PODD |
Insulet Corp
|
81,786 | $12,451,918 | |
| 5 | EW |
Edwards Lifesciences Corp
|
111,370 | $10,074,529 | |
| 6 | SYK |
Stryker Corp
|
28,828 | $9,076,207 | |
| 7 | MDT |
Medtronic plc
|
100,956 | $7,897,787 | |
| 8 | CERS |
Cerus Corp
This page
|
2,406,330 | $7,026,482 |
All Filings in CERS
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,026,482 | 2,406,330 | Shares | Other | 2026-08-11 | |
| 2026-03-31 | $4,446,697 | 2,443,241 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $4,992,906 | 2,423,741 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $3,812,772 | 2,397,970 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,409,749 | 2,418,263 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $3,225,906 | 2,320,796 | Shares | Other | 2025-05-14 | |
| 2024-12-31 | $3,341,009 | 2,169,487 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $3,728,365 | 2,142,739 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $3,771,220 | 2,142,739 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $4,051,001 | 2,143,387 | Shares | Sole | 2024-05-09 | |
| No filing history on record for this holder in this stock. | ||||||